Framework for the supply of Radiopharmaceuticals and Related Consumables - 2023
Estimated value
£100.0m
goods
Awarded value
—
Suppliers
0
Lots
2
0 awarded
Published
26 May 2023
Deadline 07 Jul 2023
Description
HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases.
Scope
- Reference
- ocds-h6vhtk-03cfab
- Total value
- £100,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
2 extensions of 12 months each
- Main category
- goods
- CPV classifications
- 093440003314000033600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | 60 | quality | — |
| Social Value | 10 | quality | — |
| — | 30 | price | — |
Submission & procedure
- Submission deadline
- 07 Jul 2023, 11:00 am
- Submission address
- https://healthtrusteurope.bravosolution.co.uk ↗
- Procedure
- Open procedure
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Agreement with Access Pricing via Direct Award for the Supply of Radiopharmaceuticals Components and Consumables | £50.0m | active |
| 2 | Agreement with Access Pricing via Direct Award for the Supply of Patient Specific Radiopharmaceuticals | £50.0m | active |